Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2024-04-05 2024-04-04
Drug Identification Number 02403943 02403943
Brand name NEUPRO NEUPRO
Common or Proper name Neupro 8mg 30 PAT iRT CA Neupro 8mg 30 PAT iRT CA
Company Name UCB CANADA INC UCB CANADA INC
Ingredients ROTIGOTINE ROTIGOTINE
Strength(s) 8MG 8MG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 30 30
ATC code N04BC N04BC
ATC description
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2024-04-02 2024-04-02
Actual start date 2024-04-03 2024-04-03
Estimated end date 2024-04-16 2024-04-16
Actual end date 2024-04-04 2024-04-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Shortage due to delay in review and lot release process. No QA event expected. Shortage due to delay in review and lot release process. No QA event expected.
Health Canada comments